🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Any postdocs interested in a position in translational immunology exploring intersection of pro-tumorigenic inflammation and resistance to immunotherapy in bladder cancer with Bhardwaj Lab and me please direct message! Horowitz Lab @Icahn School of Medicine Mount Sinai Lipschultz Precision Immunology Institute Cancer Research Institute Society for Immunotherapy of Cancer

Our detailed protocol describing how to test human antigen-specific T cell responses is out! Bhardwaj Lab STAR Protocols sciencedirect.com/science/articl…

Here is our Bhardwaj Lab recent publication at Cancer Cell spotlighting the fantastic work by Thommen Lab et al. describing an ex vivo platform to assess the early immunological responses to PD-1 blockade. nature.com/articles/s4159…

Happy to share our recent review on Lynch Syndrome and MSI-H cancers: frontiersin.org/articles/10.33… Bhardwaj Lab Vladimir Roudko Benjamin D. Greenbaum Aimee Lucas Robert Samstein Dr. Nina Bhardwaj

Very excited to share our recent work on PD-1 inhibition in advanced myeloproliferative neoplasms #mpnsm. It was fantastic to collaborate with Drs. Gaby Hobbs, Camelia Iancu-Rubin, John Mascarenhas and many more. Bhardwaj Lab doi.org/10.1182/blooda…

New from John Mascarenhas and colleagues: PD-1 inhibition in advanced myeloproliferative neoplasms | Blood Advances | American Society of Hematology ashpublications.org/bloodadvances/… Icahn School of Medicine at Mount Sinai Cansu Cimen Bozkus Bhardwaj Lab

Mullally Lab is recruiting POSTDOCS & RESEARCH TECHNICIANS to join our growing team mullallylab.bwh.harvard.edu ! Please send your CV & names of three referees to [email protected] to apply. Please RT this! @BrighamHeme Brigham and Women’s Research Dana-Farber Harvard Medical School Broad Institute

Come join our team! 🧑‍🔬 Open post-doc position investigating DC antigen presentation of tumor antigens: indeed.com/job/postdoctor…

Exciting findings on mutant CALR immunogenicity led by Mathieu Gigoux out today at Science Translational Medicine. Happy to have contributed to this amazing work. Thank you for a great collaboration Mathieu Gigoux, Taha, Jedd Wolchok, Mullally Lab, Bhardwaj Lab.

Big congratulations to my dear friend begüm aydın for receiving this prestigious HHMI fellowship #HannaGrayFellows. Well deserved!!!

How to leverage single cell technologies to accelerate T-cell based immunotherapies: see our recent report in Nature Medicine, led by Samantha Bucktrout and Abbey Cutchin, Parker Institute for Cancer Immunotherapy, 10x Genomics. nature.com/articles/s4159…

Join our team! Bhardwaj Lab

Congratulations to Nina for receiving this prestigious award.

Excited to be giving a talk about immunotherapy strategies in MPN, alongside Aaron Gerds MD, MS. Use this link to register for free: hubs.la/Q01RWS7z0 Front Line Genomics #mpnsm

🚨🧬💉Everything you wanted to know about TCR therapies* (*but were afraid to ask). Check out our new review in Nature Reviews Drug Discovery 👇. A wonderful collaboration between Klebanoff_Lab, @ND_BakerLab, Quezada Lab, and Toni Ribas. Memorial Sloan Kettering Cancer Center Parker Institute for Cancer Immunotherapy rdcu.be/dpCtp

Congratulations to our PI Dr. Nina Bhardwaj for being chosen as a Fellow of the Academy of Immuno-Oncology! A great and well-deserved honor!

Delighted to hear that our T cell immunogenicity protocol is being put to great use. Amazing work by Abdel-Wahab Lab !

Very honored to receive this award.

I encourage all my female colleagues to attend the upcoming WIN Leadership Institute. It offers a truly unique opportunity to refine leadership skills and cultivate meaningful connections. Thanks to Society for Immunotherapy of Cancer for organizing such impactful programs.

jci.org/articles/view/…